Scarica l'app Stockscreener
1.14
10.94%
-0.14
Pre-mercato:
1.18
0.04
+3.51%
Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
71.05%
0.13
|
0.076 | 0.173 | 0.169 | 0.148 |
Operating Expenses
|
17.43%
12.68
|
10.80 | 13.40 | 20.69 | 17.57 |
| Benefits Costs and Expenses |
11.11%
10.37
|
9.329 | 14.18 | -8.352 | 11.84 |
| Costs And Expenses |
11.11%
10.37
|
9.329 | 14.18 | -8.352 | 11.84 |
| Operating Income/Loss |
17.05%
-12.55
|
-10.72 | -13.23 | -20.52 | -17.42 |
| Income/Loss From Continuing Operations Before Tax |
10.61%
-10.23
|
-9.253 | -14.01 | 8.521 | -11.69 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
10.61%
-10.23
|
-9.253 | -14.01 | 8.521 | -11.69 |
|
Net Income/Loss
|
10.61%
-10.23
|
-9.253 | -14.01 | 8.521 | -11.69 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
-0.458 | - | - | - |
0.77%
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):